CSE: SONA | OTCQB: SNANF
   +1-902-442-0653   Purdy’s Wharf Tower II Suite 2001 – 1969 Upper Water Street

Category: News Releases

News & Media — News Releases

News Releases

Sona Nanotech Announces Director Retirement
January 10, 2024

Sona Nanotech Announces Director Retirement
Sona Nanotech Closes Private Placement Financing to Raise $750,000 in Gross Proceeds and Announces Additional Financing
November 27, 2023

Sona Nanotech Closes Private Placement Financing to Raise $750,000 in Gross Proceeds and Announces Additional Financing
SONA NANOTECH ARRANGES BROKERED PRIVATE PLACEMENT FINANCING (1)
October 18, 2023

Sona Nanotech Arranges Brokered Private Placement Financing
Sona’s Provide Corporate Update on Operating Activities - Sona Nanotech
October 11, 2023

Sona Provides Corporate Update on Operating Activities
Sona’s ‘THT’ Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study - Sona Nanotech (1)
September 11, 2023

Sona’s ‘THT’ Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study
Sona partnered with EXCITE International - Sona Nanotech
September 5, 2023

Sona to Engage with Medical Experts and Payors to Inform Regulatory and Commercialization Strategies for Its ‘THT’ Cancer Therapy
Targeted Hyperthermia Therapy, which leverages Sona's biocompatible Gold Nanorods
July 11, 2023

Sona Nanotech Grants Options
June 8, 2023

New NCL Assessment of Sona’s GNR Technology Highlights Process Improvement Success
Targeted Hyperthermia Therapy, which leverages Sona's biocompatible Gold Nanorods
May 30, 2023

Sona Nanotech Selects Minnetronix to Engineer Its Next Generation Targeted Hyperthermia Cancer Therapy Light Device
Targeted Hyperthermia Therapy, which leverages Sona's biocompatible Gold Nanorods
May 18, 2023

Sona Nanotech Elects New Board Chair and Is Awarded Patent
Load More
Subscribe